INDIA
India to witness very high rise in adult and children obesity
The Obesity Atlas 2023 by World Obesity Federation has said that India will see a 5.2 percent rise in adult obesity, while the rate of increase in child obesity will be 9.1 percent by 2035.
TRENDS
Bristol Myers Squibb’s India centre to augment global drug development: Samit Hirawat
The innovation centre in Hyderabad will support a global approach to patient treatment rather than India-focused treatment and be part of the global ecosystem, the executive vice president of the company underlined.
TRENDS
Max Hospital surgeons successfully remove 4.5kg tumour shaped like football from patient's stomach
The medical team at Max's facility in Saket performed an extensive six-hour surgery to extract two tumors situated at the upper region of the kidney, weighing 4.5 kg and 1 kg, respectively.
TRENDS
Takeda working with Indian government, regulator to bring dengue vaccine
‘We are very optimistic for India and the opportunity is still there. We need to work collaboratively with the government and different stakeholders on this,” Mahender Nayak, head of Asia Pacific, Takeda Pharmaceuticals, tells Moneycontrol
TRENDS
Apple exploring use of tech sensors for detecting mental health problems: Sumbul Desai
During the 20th BioAsia event in Hyderabad, Apple's Vice President of Health, Sumbul Desai, mentioned that while heart health is an essential area of focus for the company, they are also concentrating on innovation in mobility and women's health.
TRENDS
Looking to make Hyderabad world’s 'health-tech Mecca': KTR
Telangana has set the target to take the value of the lifesciences ecosystem to $250 billion by 2030, the minister has said
TRENDS
Punjab govt converting Ayushman Bharat wellness centres into mohalla clinics: Health Ministry
An official source from the Health Ministry has said that any deviations from the MoU would lead to the stoppage of funds from the Centre to the state under the Ayushman Bharat scheme.
TRENDS
Govt pharma body calls for banning e-pharmacies, alleges fake prescriptions by ghost doctors
The Pharmacy Council of India's call comes days after the drug watchdog’s show-cause notice to e-retailers; alleges that e-pharmacies are not adhering to the rule of prescriptions being digitally signed by doctors.
TRENDS
Zydus, Medtronic partner for first AI-based stroke care network in Gujarat
A team of stroke experts at Zydus hospital will visualize the CT scan performed at the remote hospital and handhold the local physician for patient management, a joint statement said
TRENDS
Biocon aims to become the largest biosimilar company globally: Kiran Mazumdar-Shaw
Biocon Chairman sees biologics business hitting Rs 2,000 crore in the fourth quarter; says there's a need to build robust regulatory system to curb instances of adulteration of drugs by Indian pharma firms.
TRENDS
Allowing greater tax deductions can fuel innovation in pharma sector: Biocon's Kiran Mazumdar-Shaw
The Biocon chairperson says India needs to figure out ways to capitalize on R&D investments for better growth prospects without impacting profitability.
TRENDS
Exclusive | Pharma manufacturing needs a robust regulatory system: Kiran Mazumdar-Shaw
Shaw appreciated the Indian pharma sector’s commitment to ethical manufacturing practices but highlighted the need for credibility and quality control.
TRENDS
Why DCGI served a show-cause notice on e-pharmacies
Online pharmacies do not comply with licence conditions like selling against a prescription, maintaining records about the sale of Schedule H drugs, and more, which can lead to drug abuse and self-medication.
TRENDS
Tata 1mg, Flipkart, Amazon among 20 e-pharmacies served DGCI notice for violating drug rules
The DGCI has said that even after the instructions from apex regulator for compliance of the order of Delhi High Court, the e-pharmacies were found to be engaged in selling medicines online without license.
TRENDS
Tata1mg focusing on expansion in Tier 3 cities, working to reduce delivery time; says CTO Gaurav Agarwal
The co-founder of the online pharmaceutical retailer wants the Centre to spell out clear guidelines on predatory pricing and heavy discounts on drugs being offered by some e-pharmacies.
TRENDS
Is uniform implementation of drug approval system a possibility in India?
In 2003, the RA Mashelkar Committee said that a strong, well-equipped, empowered, independent and professionally-managed CDSCO, which could be given the status of Central Drug Administration, reporting directly to the Ministry of Health would be the most appropriate solution.
TRENDS
Online doctor consultations in non-metros grew 87% in 2022: Report
The report said that masturbation addiction, penile enlargement, and erectile dysfunction, were some of the highest searched keywords among men across age groups.
TRENDS
Centre incentivizing R&D a positive step to encourage investment in innovation, says C.S. Muralidharan of Sun Pharma
Sun Pharma says it has a very clear strategic intent to invest in its specialty business in core therapeutic areas.
TRENDS
Akums gets DCGI nod to launch drug for uncontrolled diabetes in India
Akums, country's biggest contract drug manufacturing company (CDMO) launched Lobeglitazone tablets for improving insulin resistance in those suffering from type 2 diabetes.
TRENDS
Merge state, central drug regulators for better standards: Bharat Biotech chairman
In the past few months, there have been repeated instances of foreign drug regulators raising the red flag against medicines manufactured by Indian pharmaceutical firms
HEALTH
Chennai firm asked to halt production of eye drops linked to vision loss, death in US
The eye drops, which have been blamed for vision loss in the United States, are not sold in India, according to officials
TRENDS
Will bring new treatment options in prostate, breast and renal cancers, says Glenmark’s Alok Malik
On World Cancer Day, Alok Malik, Head of India formulations business, Glenmark Pharmaceuticals, tells Moneycontrol that the company is committed to improving access to quality cancer care
TRENDS
Max Healthcare Q3 profit rises 7% to Rs 269 crore
The average revenue per operating bed of the hospital chain has improved to Rs 66,800 from Rs 61,000. The bed occupancy stood at 77 percent in the third-quarter.
BUSINESS
Pharma industry hails budget’s 'positive thrust on research, innovation'
The industry leaders say they are waiting for the fine print of the programme aimed at supporting innovation in the pharma sector
